Pembrolizumab plus chemotherapy in frontline treatment of advanced ovarian cancer: Clinical and translational results from a phase 2 trial.
帕博利珠单抗联合化疗一线治疗晚期卵巢癌:一项 2 期试验的临床和转化结果
期刊:Med
影响因子:11.800
doi:10.1016/j.medj.2024.07.022
How Jeffrey A, Dang Minghao, Lee Sanghoon, Fellman Bryan, Westin Shannon N, Sood Anil K, Fleming Nicole D, Shafer Aaron, Yuan Ying, Liu Jinsong, Zhao Li, Celestino Joseph, Hajek Richard, Morgan Margaret B, Parra Edwin R, Laberiano Fernandez Caddie D, Arrechedera Claudio A, Solis Soto Luisa Maren, Schmeler Kathleen M, Nick Alpa, Lu Karen H, Coleman Robert, Wang Linghua, Jazaeri Amir A